These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32076639)

  • 1. Sight and switch off: Nerve density visualization for interventions targeting nerves in prostate cancer.
    You H; Shang W; Min X; Weinreb J; Li Q; Leapman M; Wang L; Tian J
    Sci Adv; 2020 Feb; 6(6):eaax6040. PubMed ID: 32076639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative assessment and postsurgical treatment of prostate cancer tumors using tumor-targeted nanoprobes.
    Teh J; Tripathi M; Reichel D; Sagong B; Montoya R; Zhang Y; Wagner S; Saouaf R; Chung LWK; Perez JM
    Nanotheranostics; 2021; 5(1):57-72. PubMed ID: 33391975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer.
    Ahmed MSU; Salam AB; Yates C; Willian K; Jaynes J; Turner T; Abdalla MO
    Int J Nanomedicine; 2017; 12():6973-6984. PubMed ID: 29033565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEG-coated and Gd-loaded fluorescent silica nanoparticles for targeted prostate cancer magnetic resonance imaging and fluorescence imaging.
    Jiang W; Fang H; Liu F; Zhou X; Zhao H; He X; Guo D
    Int J Nanomedicine; 2019; 14():5611-5622. PubMed ID: 31413566
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoacoustic Spectral Analysis for Evaluating the Aggressiveness of Prostate Cancer Labeled by Methylene Blue Polyacrylamide Nanoparticles.
    Jo J; Salfi E; Folz J; Udager AM; Keller E; Kopelman R; Kothapalli SR; Xu G; Wang X
    Biosensors (Basel); 2023 Mar; 13(3):. PubMed ID: 36979615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
    Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC
    Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH low insertion peptide mediated cell division cycle-associated protein 1 -siRNA transportation for prostatic cancer therapy targeted to the tumor microenvironment.
    Zhao Z; Li C; Song B; Sun J; Fu X; Yang F; Wang H; Yan B
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1761-1767. PubMed ID: 30131247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of Magnetic Resonance Imaging and Real-Time Elastography to Visualize Prostate Cancer: A Prospective Analysis using Whole Mount Sections after Radical Prostatectomy.
    Brock M; Roghmann F; Sonntag C; Sommerer F; Tian Z; Löppenberg B; Palisaar RJ; Noldus J; Hanske J; von Bodman C
    Ultraschall Med; 2015 Aug; 36(4):355-61. PubMed ID: 24854132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo.
    Wu X; Tai Z; Zhu Q; Fan W; Ding B; Zhang W; Zhang L; Yao C; Wang X; Ding X; Li Q; Li X; Liu G; Liu J; Gao S
    Int J Nanomedicine; 2014; 9():5431-40. PubMed ID: 25473281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel gadopentetic acid-doped silica nanoparticles conjugated with YPSMA-1 targeting prostate cancer for MR imaging: an in vitro study.
    Jiang W; He X; Fang H; Zhou X; Ran H; Guo D
    Biochem Biophys Res Commun; 2018 May; 499(2):202-208. PubMed ID: 29555471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targets missed: predictors of MRI-targeted biopsy failing to accurately localize prostate cancer found on systematic biopsy.
    Coker MA; Glaser ZA; Gordetsky JB; Thomas JV; Rais-Bahrami S
    Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):549-555. PubMed ID: 29988101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
    Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
    Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Prostate Imaging Reporting and Data System Classification in the Prediction of Tumor Aggressiveness in Targeted Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy.
    Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton GB; Froehner M; Zastrow S; Wirth MP
    Urol Int; 2017; 99(2):177-185. PubMed ID: 28531902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing prostate cancer accumulating model: combined PI-RADS v2 with prostate specific antigen and its derivative data.
    Lu YF; Zhang Q; Yao WG; Chen HY; Chen JY; Xu CC; Yu RS
    Cancer Imaging; 2019 May; 19(1):26. PubMed ID: 31122297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate.
    Labanaris AP; Engelhard K; Zugor V; Nützel R; Kühn R
    Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):65-70. PubMed ID: 19752886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
    Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
    Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
    Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
    Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate MR Imaging: An Update.
    Shaish H; Taneja SS; Rosenkrantz AB
    Radiol Clin North Am; 2017 Mar; 55(2):303-320. PubMed ID: 28126217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.